Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Exposure-Response Analyses and Disease Modeling for Selection and Confirmation of Optimal Dosing Regimen of Isatuximab in Combination Treatment in Patients with Multiple Myeloma

Fatiha Rachedi, Kimiko Koiwai, Nadia Gaudel-Dedieu, Bernard Sebastien, Hoai-Thu Thai, Raouf El-Cheikh, Claire Brillac, Jean Baptiste Fau, Laurent Nguyen, Li Liu, Frank Campana, MD, Helgi van de Velde, MD PhD, Christine Veyrat-Follet, Dorothee Semiond, PhD PharmD

Blood (2019) 134 (Supplement_1): 1897.

https://doi.org/10.1182/blood-2019-128875

Published: 2019

Journal Articles

Serum Albumin Level, but Not Nutritional Risk Index Predicts Outcomes in Acute Leukemia Patients after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Natalia N. Popova, MD, Vera A. Vasilyeva, MD PhD, Ekaterina D. Mikhaltsova, MD PhD, Olga M. Koroleva, MD, Zoya V. Konova, Anna A. Dmitrova, MD, Olga S. Starikova, MD, Ulyana V. Maslikova, MD, Maria V. Dovydenko, MD PhD, Ekterina Usikova, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 1987.

https://doi.org/10.1182/blood-2019-126822

Published: 2019

Journal Articles

Low Serum Albumin Level Predicts the Risk of Azacitidine Early Discontinuation in MDS, CMML and 20-30% AML Patients- Results from the Polaza, the Retrospective Study of the Polish Adult Leukemia Group

Blood (2019) 134 (Supplement_1): 5421.

https://doi.org/10.1182/blood-2019-125632

Published: 2019

Journal Articles

18 f-FDG PET/CT and the Revised International Staging System Are More Discriminating of Survival Outcomes in Newly Diagnosed Multiple Myeloma

Sung-Hoon Jung, MD, Seong Young Kwon, Jung-Joon Min, Hee Seung Bom, Seo-Yeon Ahn, MD, Seung-Yeon Jung, Seung-Shin Lee, MD, Moo-Rim Park, MD, Deok-Hwan Yang, MD, Jae-Sook Ahn, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 4483.

https://doi.org/10.1182/blood-2018-99-112354

Published: 2018

Journal Articles

Influence of Baseline Disease Characteristics and Exposure to Obinutuzumab on Clinical Outcome in Patients with Previously Untreated Advanced Follicular Lymphoma Treated with Obinutuzumab-Based Immunochemotherapy in the GALLIUM Trial

Candice Jamois, Ekaterina Gibiansky, Leonid Gibiansky, Vincent Buchheit, Pauline Baumlin, Denis Sahin, Guillaume Cartron, Robert Marcus, Wolfgang Hiddemann, MD PhD, John F Seymour, MBBS, PhD, Jonathan C Strefford, PhD, Georgina Meneses-Lorente, Nicolas Frey, Günter Fingerle-Rowson

Blood (2017) 130 (Supplement 1): 3848.

https://doi.org/10.1182/blood.V130.Suppl_1.3848.3848

Published: 2017

Journal Articles

Steady State Serum Albumin Level Independently Predicts Risk of Renal Dysfunction, Elevated TRV and Death in Adults with Sickle Cell Disease Screened in the Walk-Phasst Study

Nithya Sritharan, MD, Seyed Mehdi Nouraie, PhD MD, Gregory J. Kato, MD

Blood (2017) 130 (Supplement 1): 4784.

https://doi.org/10.1182/blood.V130.Suppl_1.4784.4784

Published: 2017

Journal Articles

The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Tsutomu Kobayashi, MD PhD, Junya Kuroda, MD PhD, Isao Yokota, PhD, Kazuna Tanba, MD, Tomohiko Taki, MD PhD, Takahiro Fujino, MD, Saeko Kuwahara, MD, Reiko Isa, MD, Junko Yamaguchi, MD, Eri Kawata, MD PhD, Teruaki Akaogi, MD, Hitoji Uchiyama, MD PhD, Hiroto Kaneko, MD, Nobuhiko Uoshima, MD PhD, Yutaka Kobayashi, MD PhD, Satoshi Teramukai, PhD, Masafumi Taniwaki

Blood (2015) 126 (23): 3877.

https://doi.org/10.1182/blood.V126.23.3877.3877

Published: 2015

Journal Articles

The Significance of Serum Albumin Level and Platelet Count in Patients with Diffuse Large B-Cell Lymphoma in the Context of an Enhanced International Prognostic Index (NCCN-IPI)

Yotaro Ochi, MD, Yusuke Koba, MD, Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1463.

https://doi.org/10.1182/blood.V126.23.1463.1463

Published: 2015

Journal Articles

A New Prognostic Score for Patients Older Than 60 Years with a Classical Hodgkin Lymphoma: A Retrospective Analysis on 165 Patients

Violaine Safar, MD, Nadia Oussaid, Alexandra Traverse-Glehen, MD PhD, Catherine Chassagne-Clement, MD, Catherine Sebban, MD, Anne-Sophie Michallet, MD PhD, Pierre Biron, MD, Emmanuel Bachy, MDPhD, Emmanuelle Nicolas-Virelizier, MD, Francoise Berger, MDPhD, Bertrand Coiffier, MD PhD, Gilles Salles, MDPhD, Herve Ghesquieres, MDPhD

Blood (2014) 124 (21): 1721.

https://doi.org/10.1182/blood.V124.21.1721.1721

Published: 2014

Journal Articles

Hodgkin Lymphoma in Older Patients- a Retrospective Analysis of the Polish Lyphoma Reasearch Group

Blood (2014) 124 (21): 1737.

https://doi.org/10.1182/blood.V124.21.1737.1737

Published: 2014

Journal Articles

The Prognostic Impact of Inflammatory Factors for Survival in Patients with Newly Diagnosed Multiple Myeloma Who Were Treated with Thalidomide Containing Induction Chemotherapy Underwent Autologous Stem Cell Transplantation

Cheolsu Kim, Ho Sup Lee, Yang Soo Kim, Chang-Ki Min, Je-Jung Lee, MD PhD, Kihyun Kim, MD, Dok Hyun Yoon, MD, Hyeon Seok Eom, Hyewon Lee, MD, Won Sik Lee, MD, Ho-Jin Shin, MD, PhD, Ji Hyun Lee, Yong Park, MD PhD, Jae-Cheol Jo, MD, Young Rok Do, MD, Yeung-Chul Mun

Blood (2014) 124 (21): 5896.

https://doi.org/10.1182/blood.V124.21.5896.5896

Published: 2014

Journal Articles

Effect of Severe Hypoalbuminemia on Myelosuppression and Other Toxicities of High Dose Melphalan and Autologous Stem Cell Transplantation in AL Amyloidosis Patients

Robert Meehan, MD, David Seldin, MD, John Mark Sloan, MD, Karen Quillen, MD MPH, Dina Brauneis, ANP, Anthony C Shelton, RN, Vaishali Sanchorawala, MD

Blood (2014) 124 (21): 5906.

https://doi.org/10.1182/blood.V124.21.5906.5906

Published: 2014

Journal Articles

Impact of New Therapies On the Survival of Elderly (≥75 Years of Age) Previously Untreated Patients with Multiple Myeloma in a Community Hospital

Romany Johnpulle, MD, Simran Sindhu, DO, Lynn Nichols, PhD, RN, Lynda Dimitroff, PhD, MSEd, BSN, RN, MCHES, Mehul Patel, MD, Peter Kouides, MD, Pradyumna D. Phatak, MBBS, FACP, FRCPA, Ronald L. Sham, MD, Saad Jamshed, MD

Blood (2012) 120 (21): 4251.

https://doi.org/10.1182/blood.V120.21.4251.4251

Published: 2012

Journal Articles

A Study on nm23-H1 Expression in Hodgkin Lymphoma That Was Treated with BEACOPP Therapy

Nozomi Niitsu, Kumiko Yoshitake, Hirokazu Nakamine, Masataka Okamoto

Blood (2011) 118 (21): 4861.

https://doi.org/10.1182/blood.V118.21.4861.4861

Published: 2011

Journal Articles

Comparison of Toxicity and Outcomes of BCNU-Containing Conditioning Regimens Vs LACE in Lymphoma Transplants: A Retrospective Multicenter Analysis

Navin Khattry, MD, DM, Reetu Jain, MD, Ravi Thippeswamy, MD, Adwaita Gore, DNB, Bharat Bhosale, MD, Nandish Jeevangi, MD, DM, Sadhana Kannan, MSc, Amit Joshi, MD, DM, Reena Nair, MD, Tapan Saikia, MD

Blood (2011) 118 (21): 2023.

https://doi.org/10.1182/blood.V118.21.2023.2023

Published: 2011

Journal Articles

IgD Amyloidosis: An Unrecognized Entity

Morie Abraham Gertz, MD, Francis K Buadi, M.D., Suzanne R Hayman, MD, David Dingli, M.D., Ph.D., Angela Dispenzieri, Philip R. Greipp, MD, Shaji Kumar, Martha Q Lacy, MD, John A Lust, MD, PhD, Nelson Leung, MD, S. Vincent Rajkumar, MD, Stephen J. Russell, MD, PhD, Steven R Zeldenrust, MD, PhD, Joseph R. Mikhael, MD, Vivek Roy, MD, FACP, Robert A Kyle, MD

Blood (2011) 118 (21): 5079.

https://doi.org/10.1182/blood.V118.21.5079.5079

Published: 2011

Journal Articles

Multicenter Phase II Study of the CyclOBEAP Regimen for Patients with Peripheral T-Cell Lymphoma with Analysis of Biomakers.

Nozomi Niitsu, MD, PhD, Miyuki Hayama, MD, PhD, Yuki Hagiwara, Ken Tanae, Mika Kohri, Naoki Takahashi, Shigeo Nakamura, MD, Jun-ichi Tamaru, Masataka Okamoto, MD, PhD

Blood (2010) 116 (21): 2795.

https://doi.org/10.1182/blood.V116.21.2795.2795

Published: 2010

Journal Articles

Asymptomatic Familial Factor XI Deficiency.

Juan Herrada, MD, Maria Chona Aloba, MD, Dorothy M Adcock, MD, Anuradha Gupta, MD, Luis S. Noble, MD, Mark M. Landeros

Blood (2009) 114 (22): 4449.

https://doi.org/10.1182/blood.V114.22.4449.4449

Published: 2009

Journal Articles

Gastric Diffuse Large B-Cell Lymphoma: Analyses of Prognostic Factors and Value of Pretreatment FDG-PET Scan.

Dai Chihara, MD, Yasuhiro Oki, MD, Shouji Ine, MD, PhD, Hiroshi Onoda, MD, Harumi Kato, MD, Hirofumi Taji, MD, PhD, Yoshitoyo Kagami, MD, PhD, Kazuhito Yamamoto, MD, PhD, Yasuo Morishima, MD, PhD

Blood (2009) 114 (22): 3703.

https://doi.org/10.1182/blood.V114.22.3703.3703

Published: 2009

Journal Articles

Methylation of the PTEN Promoter Leads to PTEN Inactivation in Multiple Myeloma

Giovanna Piras, Giuseppina Pala, Antonella Uras, Anna Calvisi, Maria Monne, Angelo D Palmas, Annalisa Noli, Marco Murineddu, Erika Mariane, Rosanna Asproni, Maria Antonietta Fancello, Attilio Gabbas

Blood (2008) 112 (11): 2717.

https://doi.org/10.1182/blood.V112.11.2717.2717

Published: 2008

NARROW

Exposure-Response Analyses and Disease Modeling for Selection and Confirmation of Optimal Dosing Regimen of Isatuximab in Combination Treatment in Patients with Multiple Myeloma

Serum Albumin Level, but Not Nutritional Risk Index Predicts Outcomes in Acute Leukemia Patients after Allo-HSCT

Low Serum Albumin Level Predicts the Risk of Azacitidine Early Discontinuation in MDS, CMML and 20-30% AML Patients- Results from the Polaza, the Retrospective Study of the Polish Adult Leukemia Group

18 f-FDG PET/CT and the Revised International Staging System Are More Discriminating of Survival Outcomes in Newly Diagnosed Multiple Myeloma

Influence of Baseline Disease Characteristics and Exposure to Obinutuzumab on Clinical Outcome in Patients with Previously Untreated Advanced Follicular Lymphoma Treated with Obinutuzumab-Based Immunochemotherapy in the GALLIUM Trial

Steady State Serum Albumin Level Independently Predicts Risk of Renal Dysfunction, Elevated TRV and Death in Adults with Sickle Cell Disease Screened in the Walk-Phasst Study

The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

The Significance of Serum Albumin Level and Platelet Count in Patients with Diffuse Large B-Cell Lymphoma in the Context of an Enhanced International Prognostic Index (NCCN-IPI)

A New Prognostic Score for Patients Older Than 60 Years with a Classical Hodgkin Lymphoma: A Retrospective Analysis on 165 Patients

Hodgkin Lymphoma in Older Patients- a Retrospective Analysis of the Polish Lyphoma Reasearch Group

The Prognostic Impact of Inflammatory Factors for Survival in Patients with Newly Diagnosed Multiple Myeloma Who Were Treated with Thalidomide Containing Induction Chemotherapy Underwent Autologous Stem Cell Transplantation

Effect of Severe Hypoalbuminemia on Myelosuppression and Other Toxicities of High Dose Melphalan and Autologous Stem Cell Transplantation in AL Amyloidosis Patients

Impact of New Therapies On the Survival of Elderly (≥75 Years of Age) Previously Untreated Patients with Multiple Myeloma in a Community Hospital

A Study on nm23-H1 Expression in Hodgkin Lymphoma That Was Treated with BEACOPP Therapy

Comparison of Toxicity and Outcomes of BCNU-Containing Conditioning Regimens Vs LACE in Lymphoma Transplants: A Retrospective Multicenter Analysis

IgD Amyloidosis: An Unrecognized Entity

Multicenter Phase II Study of the CyclOBEAP Regimen for Patients with Peripheral T-Cell Lymphoma with Analysis of Biomakers.

Asymptomatic Familial Factor XI Deficiency.

Gastric Diffuse Large B-Cell Lymphoma: Analyses of Prognostic Factors and Value of Pretreatment FDG-PET Scan.

Methylation of the PTEN Promoter Leads to PTEN Inactivation in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only